Embattled Appen (ASX:APX) share price bounces despite a top broker downgrade

This broker has given its verdict on the Appen share price.

| More on:
a man in a business suit rides a graphic image of an arrow that is rebounding after hitting the low point on a grid pattern that serves as a background to the image.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Appen share price is the top performer on the ASX 200 despite broker downgrade 
  • JPMorgan cut its rating on the shares to “neutral” and lowered its price target by nearly half to $7 a share 
  • Doubts over Appen’s ability to hit its 2026 targets and near-term uncertainty are the main reasons for the downgrade 

The Appen Ltd (ASX: APX) share price rallied even after a leading broker cut its recommendation on its shares.

The artificial intelligence (AI) software developer jumped 5% to $6.97 this morning – making it the top performer on the S&P/ASX 200 Index (ASX: XJO).

And in case you are wondering, the Iluka Resources Limited (ASX: ILU) share price and Paladin Energy Ltd (ASX: PDN) share price are in second and third spot.

Appen share price bucks downgrade news

But the surge in the Appen share price could puzzle some as it comes after JPMorgan lowered its rating on the shares to "neutral" from "overweight".

The broker made the downgrade following Appen's disappointing results, which missed JPMorgan's estimates.

The weakness was driven largely by Appen's New Markets division. This business failed to live up to growth expectations.

Lofty targets and near-term uncertainty

Investors would have also been put off by management's decision not to issue any more short-term guidance. If there's one thing that markets hate, it's uncertainty.

Management will instead focus on its 2026 targets and that means an increase in reinvestment in the business, noted JPMorgan.

"We believe APX's 2026 target to double revenue seems very ambitious given mgmt's recent track record," said the broker.

"Although the stock has likely oversold in the short term, the lack of visibility on growth and heightened levels of reinvestment means we would prefer to stay on the sidelines until mgmt starts delivering on their guidance."

Looking past US for support

Appen is counting on growth in non-global customers to contribute meaningfully to its 2026 targets. The number of such customers, which are essentially non-US tech giants, is tipped to grow at a 35% compound annual growth rate (CAGR).

That means this group will be contributing to around a third of Appen's revenue.

"The guidance also implies mid-single digit growth in APX's Global Services revenues," added JPMorgan.

"At this point in time we believe these targets appear to be very ambitious, given revenue growth has slowed from 11% in FY20 to 8% in FY21."

What is the Appen share price worth?

JPMorgan cut its 12-month price target on the Appen share price to $7 from $13.50 a share.

But given the 59% collapse in the Appen share price over the past year, some shareholders might just be relieved that the downgrade wasn't more severe.

Motley Fool contributor Brendon Lau owns Iluka Resources Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Appen Ltd. The Motley Fool Australia owns and has recommended Appen Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Leading broker tips 50%+ upside for IDP Education shares

The team at Macquarie thinks this beaten down stock could be a buy.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in June

The broker is feeling bullish on these names this month. Let's find out why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Bell Potter says this ASX 200 share can rise 25%

Let's see what the broker is saying about this stock.

Read more »

Stethoscope with a piggy bank in the middle.
Broker Notes

Australian health insurance: Does Macquarie prefer Medibank or NIB shares?

Medibank and NIB shares have both surged in 2025. Here’s what Macquarie expects now.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

9 ASX 200 shares just upgraded to strong buy ratings

Brokers have upgraded these shares amid expectations of price growth over the next 12 months.

Read more »

Red sell button on an Apple keyboard.
Broker Notes

Sell alert! Brokers say pull the plug on these 3 ASX 200 shares

Experts say it's time to press the sell button on these ASX 200 shares. Find out why.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

Macquarie forecasts 40% upside for this ASX All Ords stock

Let's see which stock the broker is tipping as a buy.

Read more »